300 likes | 470 Views
HEART-LUNG TRANSPLANTATION. Overall. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR. * Numbers may be low due to delayed reporting. HEART-LUNG TRANSPLANTATION ACTUARIAL SURVIVAL (1982-2001). Half-life = 2.8 years Conditional Half-life = 8.2 years. N=2,928. Survival (%).
E N D
HEART-LUNG TRANSPLANTATION Overall
NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR * Numbers may be low due to delayed reporting
HEART-LUNG TRANSPLANTATIONACTUARIAL SURVIVAL (1982-2001) Half-life = 2.8 years Conditional Half-life = 8.2 years N=2,928 Survival (%)
HEART-LUNG RECIPIENTSFunctional Status (April 1994 – December 2001)
HEART-LUNG RECIPIENTSEmployment Status(U.S.: April 1994 – December 2001)
HEART-LUNG RECIPIENTS: Rehospitalization Post-transplant(April 1994 - December 2001)
HEART-LUNG TRANSPLANTATION Adult Recipients
DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS (1982-2001) “Other” includes cancer, LAM, OB, bronchiectasis, retransplant, sarcoidosis
DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS BY ERA 1982-1990 1991-1995 1996-2001 “Other” includes OB (non-ReTX), Bronchiectasis, Sarcoidosis
ADULT HEART-LUNG RECIPIENTS Induction ImmunosuppressionFor follow-ups between October 1999 and December 2001
ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Any Time During Follow-upFor follow-ups between October 1999 and December 2001
ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between October 1999 and December 2001
ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between October 1999 and December 2001
ADULT POST-HEART-LUNG TRANSPLANT MORBIDITYCumulative Incidence of Survivors(April 1994-December 2001)
Freedom from CAV For Adult Heart-Lung Recipients(April 1994-December 2000)
Freedom from Bronchiolitis Obliterans For Adult Heart-Lung Recipients(April 1994-December 2000)
Freedom from Renal DysfunctionFor Adult Heart-Lung Recipients(April 1994-December 2000) * Renal dysfunction = Creatinine > 2.5 mg/dl, dialysis or renal transplant
MALIGNANCY POST-HEART-LUNG TRANSPLANT FOR ADULTSCumulative Incidence for Survivors(April 1994-December 2001)
Freedom from MalignancyFor Adult Heart-Lung Recipients(April 1994-December 2000)
ADULT HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(1987-2001)
HEART-LUNG TRANSPLANTATION Pediatric Recipients
AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTS (1982-2001)
AGE DISTRIBUTION FOR DONORS OF PEDIATRIC HEART-LUNG RECIPIENTS(1982-2001)
AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTSBy Year of Transplant Number of Transplants * Numbers may be low due to delayed reporting.
NUMBER OF CENTERS REPORTING PEDIATRIC HEART-LUNG TRANSPLANTS * Numbers may be low due to delayed reporting.
“Other” includes Alpha-1, Bronchiectasis, IPF and OB (non-ReTX) DIAGNOSIS IN PEDIATRIC HEART –LUNG TRANSPLANT RECIPIENTS (Age: 11-17 Years)
PEDIATRIC HEART-LUNG TRANSPLANTATIONActuarial Survival(1982-2001) Comparison between 1-10 years and 11-17 years not significant
PEDIATRIC HEART-LUNG TRANSPLANTATION Actuarial Survival by Era(1982-2001) Survival (%) No comparisons are statistically significant
PEDIATRIC HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(1987-2001)